BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27677261)

  • 21. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-coding transcriptome as a dynamic regulator of cancer metastasis.
    Crea F; Clermont PL; Parolia A; Wang Y; Helgason CD
    Cancer Metastasis Rev; 2014 Mar; 33(1):1-16. PubMed ID: 24346158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
    Gingras I; Salgado R; Ignatiadis M
    Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers.
    Yang Z; Xie L; Han L; Qu X; Yang Y; Zhang Y; He Z; Wang Y; Li J
    Theranostics; 2017; 7(12):3106-3117. PubMed ID: 28839467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNAs in gastric cancer.
    Xie S; Chang Y; Jin H; Yang F; Xu Y; Yan X; Lin A; Shu Q; Zhou T
    Cancer Lett; 2020 Nov; 493():55-70. PubMed ID: 32712234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
    Nana-Sinkam SP; Croce CM
    Mol Oncol; 2011 Dec; 5(6):483-91. PubMed ID: 22079056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid biopsy: novel technologies and clinical applications.
    Reimers N; Pantel K
    Clin Chem Lab Med; 2019 Feb; 57(3):312-316. PubMed ID: 30465714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review.
    Francavilla A; Turoczi S; Tarallo S; Vodicka P; Pardini B; Naccarati A
    Mutagenesis; 2020 Jul; 35(3):243-260. PubMed ID: 31784760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma.
    Victoria Martinez B; Dhahbi JM; Nunez Lopez YO; Lamperska K; Golusinski P; Luczewski L; Kolenda T; Atamna H; Spindler SR; Golusinski W; Masternak MM
    Oncotarget; 2015 Aug; 6(22):19246-63. PubMed ID: 26057471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
    Mohanty A; Mohanty SK; Rout S; Pani C
    Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Non-coding RNAs in Oncology.
    Slack FJ; Chinnaiyan AM
    Cell; 2019 Nov; 179(5):1033-1055. PubMed ID: 31730848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-coding RNAs in Mammary Gland Development and Disease.
    Sandhu GK; Milevskiy MJG; Wilson W; Shewan AM; Brown MA
    Adv Exp Med Biol; 2016; 886():121-153. PubMed ID: 26659490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.